跳到主要导航 跳到搜索 跳到主要内容

Electroporation of CRISPR-Cas9 into Malignant B Cells for Loss-of-Function Studies of Target Gene Via Knockout

科研成果: 书/报告/会议事项章节章节同行评审

摘要

CRISPR-Cas9 is a unique technology that enables geneticists and medical researchers to edit genomic DNA for studying biology, pathogenesis, and molecular basis of treatment in malignant B cells. Unfortunately, malignant B cells are extremely difficult to transfect by most traditional methods. In this chapter, we describe the use of the Nucleofector™ Technology-based electroporation system with optimized transfection conditions for generating a malignant B cell model, JEKO-1, with ROR1-gene knockout via CRISPR-Cas9 technology.

源语言英语
主期刊名Methods in Molecular Biology
出版商Humana Press Inc.
85-90
页数6
DOI
出版状态已出版 - 2020

出版系列

姓名Methods in Molecular Biology
2050
ISSN(印刷版)1064-3745
ISSN(电子版)1940-6029

指纹

探究 'Electroporation of CRISPR-Cas9 into Malignant B Cells for Loss-of-Function Studies of Target Gene Via Knockout' 的科研主题。它们共同构成独一无二的指纹。

引用此